Safety and efficacy data of a randomized, double-blind, placebo-controlled phase II study with the biological response modifier “bRESCAP” in patients undergoing cardiac surgery (APPIRED II)

Hiskias Keizer,Suzanne Kats, Ines Christis, Rene Heylen, Ronald Oosting, Willem Seinen,Ruud Brands

Integrative Clinical Medicine（2021）

引用 1|浏览0

暂无评分

关键词

cardiac surgery,brescap”,biological response modifier,efficacy data,double-blind,placebo-controlled

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要